EligibleTrials

Alterations in Mast Cell and Macrophage Infiltration, as Well as Micro Vessel Density

Recruiting · NCT07448896 · Observational (researchers observe without assigning treatment) · Lead sponsor: General Committee of Teaching Hospitals and Institutes, Egypt

View the official record on ClinicalTrials.gov →
Obesity

Interventions studied

bariatric surgery laparoscopic sleeve gastrectomylean control patients undergoing endoscopic biopsy for benign or malignant gastric conditions.

What this trial is about

Obesity is a global health problem that has reached epidemic proportions, affecting more than one billion people worldwide and significantly increasing the risk of multiple comorbidities, including type 2 diabetes, cardiovascular diseases, and cancer (World Health Organization, 2024). Increasing evidence suggests that chronic low-grade inflammation associated with obesity plays a critical role in the development of obesity-related malignancies, including gastric cancer. Adipose tissue dysfunction in obesity leads to the recruitment and activation of various immune cells, such as macrophages and mast cells, which contribute to a pro-inflammatory microenvironment through the release of cytokines, growth factors, and angiogenic mediators.

Who can take part

Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.